The Patent Finder

Horizon Pharma AG

Also on record
Records under this name other than patents Horizon Pharma AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to Horizon Pharma AG

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,920,838Delayed-release glucocorticoid treatment of rheumatoid disease
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,504,699Delayed-release glucocorticoid treatment of rheumatoid disease
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 6,936,695Manufacture and expression of large structural genes
Term ended
Term ended Aug 30, 2022 · USPTO record
Term endedTerm ended Aug 30, 2022USPTO record
US 6,488,960Corticosteroid formulation
Formerly held
Term ended
Term ended Sep 13, 2021 · USPTO record
Term endedTerm ended Sep 13, 2021USPTO record
US 6,677,326Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration
Formerly held
Term ended
Ended no later than Sep 13, 2021 · USPTO record
Term endedEnded no later than Sep 13, 2021USPTO record
US 6,936,694Manufacture and expression of large structural genes
Surrendered on reissue
Surrendered on reissue Sep 4, 2007 · USPTO record
Surrendered on reissueSurrendered on reissue Sep 4, 2007USPTO record
US RE39,821Manufacture and Expression of Large Structural Genes
Term ended
Term ended May 6, 2002 · Low confidence
Term endedTerm ended May 6, 2002Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited